Co-Authors
This is a "connection" page, showing publications co-authored by David Meyerholz and Christine Wohlford-Lenane.
Connection Strength
0.628
-
Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020 Oct; 60:102976.
Score: 0.226
-
Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease. J Virol. 2009 Nov; 83(21):11385-90.
Score: 0.105
-
COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021 01; 589(7843):603-607.
Score: 0.057
-
Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection. mBio. 2020 04 07; 11(2).
Score: 0.055
-
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019 07 29; 129(9):3625-3639.
Score: 0.052
-
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc Natl Acad Sci U S A. 2017 04 11; 114(15):E3119-E3128.
Score: 0.044
-
Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4. J Infect Dis. 2016 Mar 01; 213(5):712-22.
Score: 0.040
-
Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. J Virol. 2010 Mar; 84(5):2511-21.
Score: 0.027
-
Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007 Jan; 81(2):813-21.
Score: 0.022